PRGO - Perrigo Company plc Options
This page provides a detailed financial overview of Perrigo Company plc (PRGO), including its last close price, various financial ratios, stock performance metrics, and key operational data. It offers insights into the company's market capitalization, income, sales, dividend information, and insider/institutional ownership, alongside performance comparisons over different periods.
Perrigo appoints two independent directors to board
Perrigo Company plc has appointed Salman Amin and Omer Gajial as independent directors to its Board, bringing extensive experience in consumer products, retail, and digital transformation. This announcement follows recent Q1 2026 financial results showing better-than-expected EPS but lower revenue, and a leadership change with the CEO's resignation. Jefferies has adjusted Perrigo's price target to $14 from $16, maintaining a Hold rating due to industry challenges.
Price to sales forward of Perrigo Company plc – NYSE:PRGO
This article provides limited financial information for Perrigo Company plc (NYSE: PRGO), specifically focusing on its forward price-to-sales ratio. While the specific value and change are not detailed in the provided content, it indicates data availability on TradingView, covering various financial aspects of the company. It serves as a brief financial snapshot for potential investors.
Perrigo (NYSE: PRGO) appoints Salman Amin and Omer Gajial to its Board
Perrigo Company plc has appointed Salman Amin and Omer Gajial as independent directors to its Board, expanding its size from eight to ten members, effective June 30, 2026. Amin brings extensive global consumer products experience, while Gajial offers expertise in retail, e-commerce, and consumer health, with both expected to contribute to Perrigo’s strategic growth. The new directors will receive standard non-employee director compensation, and no related-party transactions were disclosed.
Enterprise value to EBIT forward of Perrigo Company plc – NYSE:PRGO
This article provides financial data for Perrigo Company plc (NYSE: PRGO), specifically focusing on its enterprise value to EBIT forward. The content is presented within the context of TradingView, a financial platform offering various market tools and data.
Perrigo Announces Appointment of Two New Independent Directors to Board
Perrigo Company plc has appointed Salman Amin and Omer Gajial as new independent directors to its Board, effective June 30, 2026. Both bring extensive experience in consumer products, retail, and digital transformation, which is expected to support Perrigo's strategic growth initiatives. Amin previously served as CEO of pladis Global, while Gajial is currently CEO of GoTo Foods and formerly an executive at Albertsons Companies.
Price to earnings forward of Perrigo Company plc – NYSE:PRGO
This page provides financial information for Perrigo Company plc (NYSE: PRGO), focusing on its forward price-to-earnings ratio. The content is primarily a data placeholder within TradingView, indicating where detailed financial metrics would typically be displayed for the company.
Price to earnings forward of Perrigo Company plc – BOATS:PRGO
This article provides financial information for Perrigo Company plc (PRGO) via the Blue Ocean Alternative Trade System (BOATS) on TradingView. It specifically focuses on the company's forward price-to-earnings ratio, though no specific values are presented in this excerpt. The content largely consists of platform navigation and disclaimers.
REG - BlackRock Group - SAR 6 - PERRIGO COMPANY PLC
BlackRock Group has disclosed an acquisition of 5,315,781 ordinary shares with voting rights in Perrigo Company PLC. This transaction brings BlackRock's total holding to 22,459,034 shares, representing 16.23% of the total voting securities in issue. The disclosure was made under Rule 6 of the Irish Takeover Panel Act, 1997, Substantial Acquisition Rules, 2007 ("SARs").
Perrigo Company plc(NYSE: PRGO) dropped from Russell 1000 Value Benchmark
Perrigo Company plc (NYSE: PRGO) has been dropped from the Russell 1000 Value Benchmark. This news follows a recent announcement that the company was concurrently added to the Russell 2000 Value Benchmark. The article provides a company profile, financial data, analyst consensus, and recent news related to Perrigo.
Perrigo Company PLC Shs Unsponsored Brazilian Depositary Receipt Repr 1 Sh
This TradingView page provides an overview of Perrigo Company PLC's unsponsored Brazilian Depositary Receipt (P1RG34) on the B3 exchange. It details financial actuals and estimates across income statements, balance sheets, and cash flow, allowing users to compare reported data with analyst projections. The platform emphasizes that the information is not investment advice and encourages users to conduct their own research.
PRGO Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Perrigo Company plc (PRGO) stock for 2027, based on analyst opinions. It details the current stock price, historical performance, financial data including earnings and revenue, and key metrics like market capitalization and EBITDA. The report also addresses frequently asked questions regarding PRGO's stock, covering volatility, dividends, employee count, and investment advice.
Perrigo edges higher amid renewed takeover speculation
Perrigo (PRGO) stock saw a modest increase following renewed speculation about a potential takeover bid. While the reasons for the speculation are unclear, the market responded positively to the rumors. There are no definitive details regarding an actual offer or interested parties.
Perrigo Company PLC (PRGO) Valuation: PE, PB & Fair Value Analysis
Perrigo Company PLC (PRGO) currently holds a valuation score of 8.61, ranking 78th out of 157 in the Pharmaceuticals industry as of June 23, 2026. The article highlights its current P/E ratio of -0.72, noting it's 0.00% below its recent high and significantly above its recent low. However, key P/B, P/S, and P/CF data have not yet been disclosed by the company.
Perrigo Co. PLC stock underperforms Monday when compared to competitors
Perrigo Co. PLC (PRGO) stock fell 6.34% on Monday, closing at $9.60, despite a mixed trading session for the broader market. The company's shares are now 66.24% below their 52-week high of $28.44 reached in July. This performance indicates underperformance relative to competitors.
Perrigo Company PLC (PRGO) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a historical overview of dividend payouts and stock splits for Perrigo Company PLC (PRGO). It details past and upcoming interim and final cash dividends, including their record, payment, and ex-dividend dates, and highlights that PRGO has distributed $574.20 million in dividends over the last five years. The report also notes the absence of any recorded stock split data.
Perrigo Company PLC (PRGO) Institutional Confidence
Perrigo Company PLC (PRGO) has an institutional shareholding score of 10.00, placing it first among 157 companies in the Pharmaceuticals industry. The institutional shareholding proportion has increased by 4.82% quarter-over-quarter, reaching 111.24%. Diamond Hill Capital is the largest institutional shareholder, holding 1.78M shares, representing 1.34% of outstanding shares.
New protective case elevates everyday use of Perrigo Company PLC medical devices
Perrigo Company PLC has introduced a new compact and reinforced protective case for its medical devices, designed to enhance safety and convenience for patients and caregivers during daily use. This accessory aims to reduce anxiety by protecting devices from damage and keeping essential components organized, reflecting Perrigo's commitment to supporting the everyday realities of its therapy users. The company views such accessories as crucial for improving patient satisfaction and adherence, thereby strengthening its market role.
New protective case elevates everyday use of Perrigo Company PLC medical devices
Perrigo Company PLC has introduced a new protective case for its medical devices, designed for daily use by patients and caregivers. The compact, reinforced case aims to enhance safety and convenience, reducing the risk of damage during transport and organizing accessories. This accessory highlights Perrigo's attention to the practical needs of its users, reinforcing trust and adherence to therapy routines.
Perrigo (PRGO) director reports RSU exercise, tax withholding and 844-unit RSU grant
Perrigo Company plc director Geoffrey M. Parker reported routine equity compensation activity. He exercised 976 restricted stock units (RSUs) into ordinary shares, had 469 shares withheld for tax obligations, and received a new grant of 844 RSUs vesting on June 12, 2027. The Form 4 filing details direct and indirect shareholdings, including through a Roth IRA and a revocable trust.
Perrigo (NYSE: PRGO) director logs RSU exercise, tax withholding and 2,559-unit grant
Perrigo Company plc director Bradley A. Alford reported an exercise of 976 Restricted Stock Units (RSUs) into Ordinary Shares, with 469 shares withheld for tax obligations. He also received a new grant of 2,559 RSUs, which will vest on June 12, 2027. Following these transactions, Alford directly holds 45,465.148 Ordinary Shares.
Perrigo Co. PLC stock underperforms Monday when compared to competitors
Perrigo Co. PLC (PRGO) stock dropped 2.64% to $10.70 on Monday, underperforming a strong market day where the S&P 500 and Dow Jones Industrial Average both saw significant gains. The company's stock closed 62.37% below its 52-week high of $28.44 reached on July 25th.
Perrigo Co. PLC stock underperforms Thursday when compared to competitors
Perrigo Co. PLC (PRGO) stock slipped 2.42% on Thursday, closing at $10.90, underperforming the broader market indexes. This marks the third consecutive day of losses for the stock, despite an overall positive trading session for the S&P 500 and Dow Jones Industrial Average.
Perrigo CEO Resigns; Board Appoints Interim Leadership
Perrigo's President and CEO, Patrick Lockwood-Taylor, resigned due to personal conduct violations, unrelated to business operations or financials. The board appointed Albert A. Manzone as interim CEO, reaffirmed the full-year 2026 financial outlook, and has initiated a search for a permanent replacement. Despite the leadership change, the company's financial performance faces challenges including large TTM losses and declining revenue, though cash generation is positive and liquidity measures are being taken.
Perrigo CEO Resigns; Board Appoints Interim Leadership
Perrigo Company's President and CEO, Patrick Lockwood-Taylor, has resigned due to personal conduct violations, effective immediately. The board has appointed Albert A. Manzone as interim President and CEO and reaffirmed its full-year 2026 financial outlook to ensure strategic continuity. Analysts currently rate PRGO stock as a Buy with a $17.00 price target, though Spark AI Analyst has a Neutral rating due to weak financial performance.
Perrigo edges higher amid renewed takeover speculation
Perrigo (PRGO) stock rose by 1.7% following renewed takeover speculation. Reports suggest Germany-based Stada Arzneimittel AG and its private equity owner, CapVest, may be interested in acquiring Perrigo, based on an "uncooked" alert from Betaville.
Perrigo (PRGO) EVP settles RSUs as 17,902 shares, 9,346 withheld for taxes
Perrigo Co plc EVP and President of CSCI, Roberto Khoury, exercised Restricted Stock Units (RSUs) on June 5, 2026, converting into 17,902 ordinary shares valued at $10.83 per share. Concurrently, 9,346 ordinary shares were withheld to cover tax obligations. These transactions represent routine equity compensation vesting and are not discretionary buying or selling of Perrigo stock.
Perrigo (PRGO) ex-CEO exercises RSUs, 12,906 shares withheld for tax
Perrigo Company plc's former CEO, Patrick Lockwood-Taylor, reported the exercise of 25,230 Restricted Stock Units (RSUs) into ordinary shares. To cover tax obligations, 12,906 ordinary shares were disposed of at $10.83 per share. Following these compensation-related transactions, Lockwood-Taylor directly holds 136,076 ordinary shares and 50,458 RSUs, indicating an exercise-and-tax-withholding event rather than an open-market sale or purchase.
Perrigo’s Path to Recovery Unclear Amid Category Weakness, New Leader, and Infant Formula Pressure
Perrigo, now a pure-play consumer healthcare company, faces an uncertain recovery path due to category weakness, a leadership transition, and infant formula pressures. The company is the largest private-label OTC manufacturer in the US and expects low single-digit growth in its private-label business over the next five years. While a new leader could be strategic, challenges remain in the fragmented OTC market.
Perrigo CEO resigns; reaffirms FY 2026 guidance
Perrigo's CEO, Murray S. Kessler, has resigned from his position and the board of directors, effective immediately. Patrick Lockwood-Taylor, currently President, Consumer Self-Care Americas, has been appointed as his successor. The company reaffirmed its financial guidance for fiscal year 2026, including organic net sales growth, adjusted operating margin improvement, and adjusted diluted EPS growth.
Perrigo (PRGO) EVP and CSO reports RSU exercise and tax-withholding share disposition
Perrigo Company plc's EVP and CSO, Abigail Lennox, reported the exercise of 3,823 Restricted Stock Units (RSUs) into ordinary shares at a reference price of $10.83 per share. Concurrently, 1,996 shares were disposed of to cover tax liabilities. Following these transactions, Lennox directly holds 4,607 ordinary shares, with the reported activities primarily related to equity compensation and tax withholdings rather than open-market trades.
Perrigo Announces Leadership Transition
Perrigo Company plc has appointed Albert A. Manzone as Interim President and CEO, following the resignation of Patrick Lockwood-Taylor due to personal conduct inconsistent with company values. Manzone, a current board member, will lead the company while a permanent successor is sought. Perrigo reaffirms its full-year 2026 financial outlook.
Perrigo (NYSE: PRGO) CEO exits as company reiterates 2026 outlook
Perrigo Company plc announced that its CEO, Patrick Lockwood-Taylor, has resigned immediately due to personal conduct inconsistent with the company's Code of Conduct, though not related to business operations or financial reporting. Albert A. Manzone, a current director, has been appointed Interim President and CEO while a search for a permanent successor is underway. Despite the leadership change, Perrigo reaffirmed its full-year 2026 financial outlook, including sales and adjusted EPS guidance.
Perrigo stock slips as CEO resigns over conduct issues
Perrigo Company plc's shares dropped after CEO Patrick Lockwood-Taylor resigned due to personal conduct issues inconsistent with the company's values. Current board member Albert A. Manzone has been appointed as interim CEO, and the company has reaffirmed its full-year 2026 financial outlook. The conduct in question did not involve company business or financial reporting.
Perrigo CEO Patrick Lockwood-Taylor resigns over conduct violations
Perrigo CEO Patrick Lockwood-Taylor has resigned following conduct violations. The article, published by Crain's Grand Rapids Business, notes his departure but does not provide details on the nature of the violations. The resignation was announced on June 08, 2026.
Perrigo Stock: This 11% Yielder Should Cut The Dividend (NYSE:PRGO)
Perrigo (PRGO) is rated Hold due to its distressed balance sheet, high leverage, and an unsustainable 10.9% dividend yield not covered by free cash flow. While recent asset sales offer short-term relief, they dilute margins and underscore the need for portfolio consolidation. The company must reduce debt, streamline its product portfolio, and restore cash flow to sustainably cover its dividend and stabilize its financial position.
Perrigo stock gains nearly 5% on earnings beat despite revenue miss
Perrigo Company plc (NYSE:PRGO) reported first-quarter results that surpassed earnings estimates but missed revenue expectations. Despite a revenue decline of 7.2% year-over-year, driven by lower consumption and retailer inventory levels, the company's shares rose nearly 5% in pre-market trading as adjusted EPS beat analyst predictions and full-year guidance was maintained. Perrigo anticipates second-half improvement and recently sold its Dermacosmetics business to reduce debt.
Perrigo Co. PLC stock underperforms Tuesday when compared to competitors
Perrigo Co. PLC (PRGO) stock declined by 2.79% to $10.46 on Tuesday, underperforming the broader market. This marked the third consecutive day of losses for the stock, despite a positive trading session where the S&P 500 Index and the Dow Jones Industrial Average both saw gains.
How Perrigo Company Plc (PRGO) Affects Rotational Strategy Timing
Quantitative Research Desk provides an analysis of Perrigo Company Plc (PRGO) indicating neutral readings in shorter horizons but a weak long-term bias. The analysis includes AI-generated trading strategies for various risk profiles, featuring long, breakout, and short positions with specific entry, target, and stop-loss levels. Support and resistance levels are also identified across different time horizons.
How Perrigo Company Plc (PRGO) Affects Rotational Strategy Timing
This article analyzes Perrigo Company Plc (PRGO) using AI models to determine its effect on rotational strategy timing. It highlights stable neutral readings in shorter horizons potentially easing a long-term weak bias and identifies compelling upside potential due to no resistance levels above the current price. The analysis includes various trading strategies—position, momentum breakout, and risk hedging—along with multi-timeframe signal analysis for different horizons.
Perrigo Co. PLC stock underperforms Monday when compared to competitors
Perrigo Co. PLC's stock (PRGO) fell 2.62% to $10.76 on Monday, underperforming the broader market which saw the S&P 500 Index rise by 0.26% and the Dow Jones Industrial Average gain 0.09%. This marks the second consecutive day of losses for the company's stock.
Thompson Siegel & Walmsley LLC Has $64.85 Million Holdings in Perrigo Company plc $PRGO
Thompson Siegel & Walmsley LLC increased its stake in Perrigo Company plc by 28.4% in the fourth quarter, bringing its total holdings to 4.66 million shares valued at approximately $64.8 million. Despite mixed but cautious analyst sentiment, with a consensus "Hold" rating and an average price target of $19.33, Perrigo reported better-than-expected EPS of $0.43 for the quarter, though revenue fell short of estimates. The company also announced a quarterly dividend of $0.29, reflecting a 10.5% annualized yield.
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc announced that its President and CEO, Patrick Lockwood-Taylor, and CFO, Eduardo Bezerra, are scheduled to present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on Tuesday, June 9th at 10:30 AM EDT. Interested parties can access a webcast of the presentation on the Perrigo investor relations website. The company is a leading global provider of consumer products, focusing on over-the-counter self-care solutions primarily in North America and Europe.
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc announced that its President and CEO, Patrick Lockwood-Taylor, will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference. The event is scheduled for June 12, 2026, at 11:30 AM ET. A live webcast of the presentation will be available on the company's website.
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc announced that its President and CEO, Patrick Lockwood-Taylor, and CFO, Eduardo Bezerra, will present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on Tuesday, June 9th at 10:30 AM EDT. The presentation will be available via webcast on the Perrigo investor relations website. Perrigo is a leading pure-play consumer health company focused on over-the-counter self-care solutions.
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc announced that its President and CEO, Patrick Lockwood-Taylor, and CFO, Eduardo Bezerra, are scheduled to present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference. The presentation will take place on Tuesday, June 9th at 10:30 AM EDT and can be accessed via webcast on Perrigo's investor relations website. Perrigo is a leading global provider of consumer health products, focusing on over-the-counter self-care solutions.
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc announced that its President and CEO, Patrick Lockwood-Taylor, and CFO, Eduardo Bezerra, will present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference. The presentation is scheduled for Tuesday, June 9th at 10:30 AM EDT and will be accessible via webcast on the company's investor relations website. The company is a leading pure-play consumer health company focused on over-the-counter self-care solutions in North America and Europe.
Perrigo (PRGO) CFO awarded 52,678 RSUs, now holds 77,760 ordinary shares
Perrigo Company plc's EVP & Chief Financial Officer, Eduardo Guarita Bezerra, was granted 52,678 Restricted Stock Units (RSUs) that will vest in three equal annual installments starting May 13, 2027. Following this grant, Mr. Bezerra now directly holds 77,760 ordinary shares and the newly awarded 52,678 RSUs. This equity compensation aligns his interests with the company's share performance over time.
Perrigo (NYSE: PRGO) director logs RSU grant, vesting and tax share disposition
Perrigo Company plc director Jonas Samuelson reported equity activity including receiving 16,681 Restricted Stock Units (RSUs) on May 13, 2026, which are set to vest on May 13, 2027. On May 14, 2026, 7,305 RSUs vested and converted into ordinary shares, and 3,507 ordinary shares were disposed of at $10.84 each to cover tax obligations. Following these transactions, Samuelson directly owns 5,392 ordinary shares, with the newly granted RSUs still outstanding.
Perrigo (PRGO) director reports RSU grant, exercise and tax-withholding share disposition
Perrigo Company plc director Donal O'Connor reported recent equity compensation activities. He exercised 7,305 Restricted Stock Units (RSUs) and had 3,507 Ordinary Shares withheld at $10.84 per share to cover tax obligations. Additionally, O'Connor received a new grant of 16,681 RSUs, which will vest on May 13, 2027.
